MIMS news

Oral psoriatic arthritis treatment accepted for NHS use

Oral psoriatic arthritis treatment accepted for NHS use

Apremilast (Otezla) has been approved by NICE for treating...

Cardiac warning for anticholinergic injection

Cardiac warning for anticholinergic injection

Hyoscine butylbromide (Buscopan) injection should be...

Infographic: Underprescribing widespread among patients at risk of stroke

Infographic: Underprescribing widespread among patients at risk of stroke

Improved prescribing of lipid-lowering, anticoagulant...

Salmeterol/fluticasone dry powder inhaler approved for asthma

Salmeterol/fluticasone dry powder inhaler approved for asthma

AirFluSal Forspiro (salmeterol/fluticasone) is now...

Idebenone launched as first treatment for mitochondrial eye disease

Idebenone launched as first treatment for mitochondrial eye disease

Patients with Leber's hereditary optic neuropathy (LHON)...

NICE approves mepolizumab for refractory eosinophilic asthma

NICE approves mepolizumab for refractory eosinophilic asthma

Mepolizumab may be used within the NHS for the treatment...

MHRA highlights drug interaction risk for hepatitis C antivirals

MHRA highlights drug interaction risk for hepatitis C antivirals

INR should be monitored closely in hepatitis C patients...

New combination tablet for type II diabetes

New combination tablet for type II diabetes

Qtern contains a fixed-dose combination of saxagliptin...

MHRA advises caution when co-prescribing steroids and HIV-treatment boosters

MHRA advises caution when co-prescribing steroids and HIV-treatment boosters

Concomitant use of corticosteroids with ritonavir or...

Renal impairment warnings relaxed for metformin products

Renal impairment warnings relaxed for metformin products

Metformin-containing products can now be used in patients...

Liraglutide provides new weight loss option for overweight and obese adults

Liraglutide provides new weight loss option for overweight and obese adults

The antidiabetic drug liraglutide is now available...

NICE approves drugs for NSCLC and multiple myeloma

NICE approves drugs for NSCLC and multiple myeloma

NICE has approved pembrolizumab for use in non-small-cell...

Infographic: Improved steroid inhaler prescribing sees £2 million reduction in monthly spend

Infographic: Improved steroid inhaler prescribing sees £2 million reduction in monthly spend

Optimising prescribing of high-dose steroid inhalers...

Psychiatric advice issued for psoriasis treatment

Psychiatric advice issued for psoriasis treatment

The prescribing information for apremilast (Otezla)...

Flu antivirals now prescribable at NHS expense

Flu antivirals now prescribable at NHS expense

Antivirals for the treatment and prophylaxis of influenza...

Palbociclib provides new option in breast cancer

Palbociclib provides new option in breast cancer

Palbociclib (Ibrance) is licensed for use in combination...

New tiotropium inhaler for COPD patients

New tiotropium inhaler for COPD patients

Braltus uses the new Zonda inhaler to deliver the same...

Infographic: Antibiotic prescribing 'decreasing faster than ever'

Infographic: Antibiotic prescribing 'decreasing faster than ever'

Analysis of GP prescribing data from August 2010 to...

New single-tablet option for hepatitis C

New single-tablet option for hepatitis C

Zepatier (elbasvir/grazoprevir) is a once-daily, single-tablet...

NICE approves apremilast for refractory psoriasis

NICE approves apremilast for refractory psoriasis

In new guidance NICE recommends the use of apremilast...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.